AI and Machine Learning to propel Indian pharma industry in 2025

Technological advancements like Artificial Intelligence (AI), Machine Learning, and precision medicine are set to revolutionise the Indian pharmaceutical industry, bringing about a profound transformation by 2025. With a focus on innovation, global accessibility, and quality improvement, the industry is expected to grow from its current size of $58 billion to $130 billion by 2030, according to experts.

The pharma industry, accounting for 20% of global generic drug sales, is making strides in speciality drugs, CAR-T cell therapy, mRNA vaccines, and biosimilars, leveraging opportunities from patent expiries of biologics. The healthcare and med-tech sectors are also expanding rapidly.

The hospital market is projected to grow from $99 billion in 2023 to $194 billion by 2032, while the diagnostics industry is expected to double in size by 2028. Industry leaders emphasise the integration of AI, robotics, and telemedicine to improve patient outcomes and enhance operational efficiency.

As India strengthens its regulatory framework and fosters ethical practices, it is poised to become a global leader in healthcare innovation, transforming lives worldwide.